Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The mystery of the third signal

14.09.2012
In COPD, several mechanisms, which normally protect the lungs from the body's own immune cells, cease to function properly.

At least three protective mechanisms defend the lungs against erroneous attacks by the body's own immune system. This was discovered by the Immuneregulation research group headed by Professor Dunja Bruder at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany.


Lungs under the microscope: The left image shows healthy lung tissue. If the immune system attacks lung tissue by mistake, immune cells, depicted in blue, accumulate and may constrict the bronchi. This can be seen in the right image.

In the case of chronic obstructive pulmonary diseases, briefly COPD, a group of common diseases, whose etiology has been linked to smoking or an individual's prolonged exposure to harmful dust particles, these mechanisms apparently cease to function properly. The researchers have now published their findings in the current issue of the American Journal of Respiratory Cell and Molecular Biology.

The lung surfaces separate the body from the external environment. It is particularly important that, here, the immune system is able to recognize and fight off harmful substances while sparing the body's own structures. When a certain type of immune cells - called T cells – is produced in the body, the unfortunate by-product is the development of dysfunctional T cells capable of attacking the body itself. Before they become active in the body, a control mechanism selects and destroys dysfunctional T cells. On a quite regular basis, however, some of these cells, called autoreactive T cells, evade detection by the control mechanisms and thus end up staying in the body, where they can pose a threat on the different tissues. As it turns out, in the case of COPD, autoreactive T cells play a rather important - and previously underestimated - role.
COPD is by now the fourth most common cause of death in industrialized countries. An effective COPD therapy, however, does not yet exist. Smokers and those exposed to badly polluted air have an increased risk of developing the disease. Among other factors, the smouldering hearths in closed rooms, which are still being used for cooking and heating in developing countries, should be mentioned here. "It is certainly true that, for development of COPD, which is commonly known as 'smoker's cough', smoking and dust exposure are two important risk factors. The inflammation which results, could, however, lead to T cells attacking the lung tissue, ultimately resulting in the development of an autoimmune disorder," explains HZI scientist Marcus Gereke.

Gereke is part of a team of HZI scientists that, together with colleagues from the Free University Berlin, the University Hospital Essen, and the Otto-von-Guericke University Magde-burg, has been studying the lungs' inherent protective mechanisms that ward off potential attacks by a person's misguided immune system. In the process, they discovered that autoreactive T cells, which recognize "self" lung tissue, do not by themselves automatically trigger COPD, but that other factors also play a role. The researchers are especially interested in a subgroup of T cells, which is normally in charge of recognizing and destroying infected cells to prevent pathogens from spreading. They are part of the acquired immune response, which adapts to newly introduced pathogens throughout a person's life, targeting them for destruction. A year ago, the scientists were already able to show that the cells in question also attack chronically inflamed lung alveoli.

To understand the role of T cells in the etiology of COPD, the researchers conducted experiments in mice, in which they were able to specifically evoke autoimmunity by introducing autoreactive T cells into the murine lungs. Against expectations, however, they found that the mere presence of cells that are viewed as "non-self" did not by itself provoke an attack by autoreactive T cells. Instead, it appears that, besides erroneously recognizing a tissue as "non-self," the autoreactive T cells require an additional signal to prompt their differentiation into cells capable of attacking "self" cells. To their surprise, the scientists found that the T cells became activated only temporarily once the scientists delivered an additional, second signal by triggering the innate immune response - a kind of "body alarm system" that switches on the entire immune defense. "It seems that a third signal is needed to completely turn on these cells. Once we find out what this third signal actually is, we will have taken an important step forward in our understanding of COPD. This would then allow us to intervene therapeutically and prevent the progress of the disease," emphasizes Dunja Bruder the relevance of their results. The researchers' investigations point to the fact that chronic infections may be responsible for producing the third signal. Infections lead to inflammation of the lungs, which then completely turns on the autoreactive T cells.

The researchers assume that similar processes may occur in a smoker's lungs. Certain substances in cigarette smoke damage the mucosa of the lungs. This in turn exposes structures that are then recognized by immune cells. The innate immune system is constantly being activated and licenses the autoreactive T cells to attack and destroy the lung tissue. In the chronically inflamed lung tissue of heavy smokers, the protective mechanisms are effectively shut down. All too often, the outcome is the development of COPD.

Original publication:
Milena J. Tosiek, Sophie R. Bader, Achim D. Gruber, Jan Buer, Marcus Gereke, Dunja Bruder
CD8+ T cells responding to alveolar self-antigen lack CD25 expression and fail to precipitate autoimmunity
American Journal of Respiratory Cell and Molecular Biology 2012
doi: 10.1165/rcmb.2011-0387OC

The Helmholtz Centre for Infection Research
At the Helmholtz Centre for Infection Research in Braunschweig, scientists study microbial virulence factors, host-pathogen interactions and immunity. The goal is to develop strategies for the diagnosis, prevention and therapy of human infectious diseases.
http://www.helmholtz-hzi.de/en

The research group "Immuneregulation" at the HZI explores the immune system under extreme situations. These can be parallel infections with different pathogens or the erroneous attack of parts of the own body by the immune system.

Dr. Birgit Manno | Helmholtz-Zentrum
Further information:
http://www.helmholtz-hzi.de/en
http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/the_mystery_of_the_third_signal/

More articles from Life Sciences:

nachricht Biofuel produced by microalgae
28.02.2017 | Tokyo Institute of Technology

nachricht Decoding the genome's cryptic language
27.02.2017 | University of California - San Diego

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Safe glide at total engine failure with ELA-inside

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded after a glide flight with an Airbus A320 in ditching on the Hudson River. All 155 people on board were saved.

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded...

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Scientists reach back in time to discover some of the most power-packed galaxies

28.02.2017 | Physics and Astronomy

Nano 'sandwich' offers unique properties

28.02.2017 | Materials Sciences

Light beam replaces blood test during heart surgery

28.02.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>